Pharmacopoeia and its importance in pharmaceutical analysis MCQs With Answer

Pharmacopoeia are authoritative compendia of standards that define quality, identity, purity and strength of drugs and excipients, forming the backbone of pharmaceutical analysis. For B.Pharm students, understanding pharmacopoeial monographs, official assays, identification tests, limits for impurities, reference standards (USP, BP, IP) and analytical methods (HPLC, GC, titration, dissolution) is essential for quality control and regulatory compliance. Pharmacopoeia guide formulation testing, stability assessment, sterility and potency evaluation, ensuring patient safety and product efficacy. Mastery of these concepts equips future pharmacists to interpret monographs, validate methods and apply standards in the lab and industry. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. What is the primary purpose of a pharmacopoeia?

  • To provide marketing guidelines for pharmaceutical companies
  • To list all possible adverse drug reactions
  • To set official standards for identity, purity and strength of medicines
  • To publish clinical trial data

Correct Answer: To set official standards for identity, purity and strength of medicines

Q2. Which of the following is an example of a national pharmacopoeia?

  • International Conference on Harmonisation (ICH)
  • United States Pharmacopeia (USP)
  • World Health Organization Model List
  • European Medicines Agency guidelines

Correct Answer: United States Pharmacopeia (USP)

Q3. A pharmacopoeial monograph typically includes which of these sections?

  • Marketing strategy and cost analysis
  • Identification, assay, and impurity limits
  • Patient counseling scripts
  • Clinical efficacy comparisons

Correct Answer: Identification, assay, and impurity limits

Q4. Which analytical technique is commonly specified in pharmacopoeial assays for quantification of drugs?

  • Thin layer chromatography for potency measurement
  • High-performance liquid chromatography (HPLC)
  • Light microscopy
  • Paper chromatography for all assays

Correct Answer: High-performance liquid chromatography (HPLC)

Q5. What is a pharmacopoeial reference standard?

  • A guideline for clinical use of a drug
  • An official chemical substance used for assay calibration
  • A marketing sample used for stability studies
  • An internal company control not recognized by regulators

Correct Answer: An official chemical substance used for assay calibration

Q6. Which term describes impurities structurally related to the drug substance?

  • Foreign contaminants
  • Related substances
  • Excipients
  • Placebos

Correct Answer: Related substances

Q7. What legal status do pharmacopoeial standards typically have in many countries?

  • Advisory only, never enforceable
  • Scientific suggestions without legal effect
  • Statutory or regulatory force when referenced in law
  • Confidential internal documents for manufacturers

Correct Answer: Statutory or regulatory force when referenced in law

Q8. Which test in a monograph confirms the chemical identity of a drug?

  • Assay only
  • Identification tests such as IR or specific chemical reactions
  • Dissolution testing only
  • Uniformity of dosage units

Correct Answer: Identification tests such as IR or specific chemical reactions

Q9. A titrimetric assay in a pharmacopoeial monograph is primarily used to determine:

  • Microbial contamination
  • Particle size distribution
  • Drug content or potency
  • Packaging integrity

Correct Answer: Drug content or potency

Q10. Which pharmacopoeial test evaluates the rate and extent of drug release from a dosage form?

  • Dissolution testing
  • Sterility testing
  • Titratable acidity
  • Assay for moisture content

Correct Answer: Dissolution testing

Q11. What is the purpose of limit tests in pharmacopoeial analysis?

  • To measure therapeutic efficacy
  • To detect and quantify impurities or contaminants below a specified limit
  • To determine packaging aesthetics
  • To replace full quantitative assays

Correct Answer: To detect and quantify impurities or contaminants below a specified limit

Q12. Which pharmacopoeial compendia are commonly harmonized efforts aim to align?

  • USP, BP, and IP
  • WHO list and company SOPs only
  • Local hospital formularies
  • Pharmaceutical marketing brochures

Correct Answer: USP, BP, and IP

Q13. What distinguishes a primary reference standard from a working standard?

  • Primary standards are used only for microbiological tests
  • Primary standards are highly characterized and used to calibrate working standards
  • Working standards are more pure than primary standards
  • There is no difference; terms are interchangeable

Correct Answer: Primary standards are highly characterized and used to calibrate working standards

Q14. Which analytical parameter assesses consistency of active ingredient among individual tablets?

  • Limit test
  • Content uniformity
  • Related substances test
  • pH measurement

Correct Answer: Content uniformity

Q15. A stability-indicating method is required to:

  • Measure only the initial potency of a drug
  • Accurately separate and quantify drug and its degradation products
  • Replace all pharmacopoeial identification tests
  • Assess only microbial contamination over time

Correct Answer: Accurately separate and quantify drug and its degradation products

Q16. Which technique is preferred for volatile impurity profiling in certain monographs?

  • HPLC with UV detection
  • Gas chromatography (GC)
  • Light scattering detector only
  • IR spectroscopy exclusively

Correct Answer: Gas chromatography (GC)

Q17. What role do excipient monographs in pharmacopoeias play?

  • They define therapeutic doses of excipients
  • They set specifications for identity, purity and functional quality of excipients
  • They are optional marketing guides
  • They list contraindications for excipients

Correct Answer: They set specifications for identity, purity and functional quality of excipients

Q18. Which is a common identification test specified by pharmacopoeias for organic drugs?

  • pKa determination only
  • Infrared (IR) absorption spectroscopy
  • Particle size analysis
  • Color of the packaging

Correct Answer: Infrared (IR) absorption spectroscopy

Q19. Pharmacopoeial monographs are revised periodically to address:

  • Changes in pharmaceutical marketing trends
  • Advances in analytical methods, safety data and impurity concerns
  • Company preferences
  • Seasonal variations in raw material cost

Correct Answer: Advances in analytical methods, safety data and impurity concerns

Q20. What is the difference between ‘assay’ and ‘identification’ in a monograph?

  • Assay confirms identity; identification measures strength
  • Assay quantifies amount of active substance; identification verifies chemical identity
  • They are the same test with different names
  • Identification evaluates stability; assay checks packaging

Correct Answer: Assay quantifies amount of active substance; identification verifies chemical identity

Q21. Which dissolution apparatus is commonly referenced in USP for tablets?

  • Paddle apparatus (USP Apparatus II)
  • Flow-through cell only
  • Vortex mixer
  • High-speed centrifuge

Correct Answer: Paddle apparatus (USP Apparatus II)

Q22. What is the significance of ‘related substances’ testing for drug safety?

  • It assesses aesthetic properties of the tablet
  • It detects impurities that may be toxic or reduce efficacy
  • It is only important for sterile products
  • It replaces the need for stability testing

Correct Answer: It detects impurities that may be toxic or reduce efficacy

Q23. In pharmacopoeial context, a ‘monograph’ refers to:

  • A marketing leaflet for healthcare professionals
  • A detailed specification document for a specific drug substance or product
  • A patient instruction manual
  • An internal lab notebook

Correct Answer: A detailed specification document for a specific drug substance or product

Q24. Which statement about pharmacopoeial methods and company methods is true?

  • Company methods never need to be validated
  • Company methods must be shown equivalent to pharmacopoeial methods if used for official testing
  • Pharmacopoeial methods are optional in regulatory submissions
  • Company methods always supersede pharmacopoeial methods

Correct Answer: Company methods must be shown equivalent to pharmacopoeial methods if used for official testing

Q25. What is the role of the International Pharmacopoeia published by WHO?

  • To replace all national pharmacopoeias immediately
  • To provide international guidance on quality specifications for global public health needs
  • To provide marketing authorization templates
  • To publish clinical trial results

Correct Answer: To provide international guidance on quality specifications for global public health needs

Q26. Which parameter measured in pharmacopoeial tests helps ensure uniform dose delivery in capsules?

  • pH of the capsule shell only
  • Weight variation and content uniformity
  • Discoloration index
  • Osmolality of contents

Correct Answer: Weight variation and content uniformity

Q27. Certificate of Analysis (CoA) differs from a pharmacopoeial monograph because a CoA:

  • Is a legal compendial document published by the government
  • Reports specific batch test results, whereas a monograph sets general specifications
  • Contains pharmacokinetic profiles
  • Is identical to a monograph

Correct Answer: Reports specific batch test results, whereas a monograph sets general specifications

Q28. Which validation parameter ensures a chromatographic method produces correct results across its measuring range?

  • Specificity only
  • Linearity and accuracy
  • Color of the solvent
  • Package label design

Correct Answer: Linearity and accuracy

Q29. Why are pharmacopoeial microbial tests important for sterile products?

  • They measure tablet hardness
  • They verify sterility and bioburden limits to protect patient safety
  • They predict clinical efficacy directly
  • They assess only environmental cleanliness

Correct Answer: They verify sterility and bioburden limits to protect patient safety

Q30. Harmonization of pharmacopoeial standards aims to:

  • Increase variability in monographs between countries
  • Align tests and specifications to facilitate trade and regulatory convergence
  • Eliminate the need for analytical testing
  • Limit access to reference standards

Correct Answer: Align tests and specifications to facilitate trade and regulatory convergence

Leave a Comment